Targeting the EGF receptor in ovarian cancer with the tyrosine kinase inhibitor ZD 1839 ("Iressa").

Source:http://linkedlifedata.com/resource/pubmed/id/11875715

Br. J. Cancer 2002 Feb 1 86 3 456-62

Download in:

View as

General Info

PMID
11875715